Clinical predictors and mortality of postoperative pneumonia following pulmonary resection in patients with lung cancer: A systematic review and meta-analysis.
메타분석
1/5 보강
Postoperative pneumonia (POP) represents a significant complication in lung cancer (LC) patients following lung resection, contributing to poor outcomes.
- p-value P < 0.001
- OR 0.575
- 연구 설계 systematic review
APA
Sheervalilou M, Ghanei M, Arabfard M (2026). Clinical predictors and mortality of postoperative pneumonia following pulmonary resection in patients with lung cancer: A systematic review and meta-analysis.. Lung India : official organ of Indian Chest Society, 43(1), 67-77. https://doi.org/10.4103/lungindia.lungindia_253_25
MLA
Sheervalilou M, et al.. "Clinical predictors and mortality of postoperative pneumonia following pulmonary resection in patients with lung cancer: A systematic review and meta-analysis.." Lung India : official organ of Indian Chest Society, vol. 43, no. 1, 2026, pp. 67-77.
PMID
41474431 ↗
Abstract 한글 요약
Postoperative pneumonia (POP) represents a significant complication in lung cancer (LC) patients following lung resection, contributing to poor outcomes. This systematic review and meta-analysis aimed to identify clinical predictors and outcomes of POP in LC. A systematic search was conducted in EBSCOhost, Embase, PubMed/MEDLINE, Scopus, and Web of Science, with screening and reporting following preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Meta-analyses were performed in Jamovi 2.3.28, reporting results as odds ratios (OR) or standardised mean differences (SMD). Egger's test and Fail-safe N were used to assess publication bias and evidence robustness (PROSPERO: CRD42024551104). A total of 17 studies encompassing 21,104 LC patients (1,610 with POP and 19,494 without) were included. Reduced FEV1 (SMD: -0.48, 95%CI: [- 0.61, -0.36], P < 0.001) predicted POP. Surgical predictors of POP included VATS (OR: 0.575, 95%CI: [0.448, 0.737], P < 0.001), segmentectomy (OR: 0.459, 95%CI: [0.261, 0.805], P = 0.007), wedge resection (OR: 1.828, 95%CI: [1.189, 2.809], P = 0.006), lobectomy (OR: 0.626, 95%CI: [0.488, 0.803], P < 0.001), bilobectomy (OR: 2.367, 95%CI: [1.408, 3.979], P = 0.001), and pneumonectomy (OR: 1.750, 95%CI: [1.178, 2.600], P = 0.006). Left lung tumours increased POP risk (OR: 1.254, 95%CI: [1.050, 1.499], P = 0.013), while right lung tumours were protective (OR: 0.801, 95%CI: [0.670, 0.975], P = 0.015). POP was associated with longer surgery (SMD: 0.22, 95% CI: [0.11, 0.34], P < 0.001), extended hospitalisation (SMD: 1.19, 95%CI: [1.07, 1.30], P < 0.001), and significantly higher overall mortality OR: 12.12, 95% CI: [5.540, 26.550], P < 0.001). POP in LC patients is influenced by respiratory function, surgical approach, and tumour location, and predicts poor survival, emphasising the need for preventive strategies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.